Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.39 +0.04 (+2.96%)
At close: Sep 30, 2026 · 4:00 PM EDT

Alx Oncology Holdings (ALXO) EBITDA Margin (2019 - 2020)

Updated

Alx Oncology Holdings' EBITDA Margin came in at -3676.90% for FY2020, down 3285.87 percentage points from -391.03% in FY2019.

Analysis

Alx Oncology Holdings (ALXO) EBITDA Margin (2019 - 2020) Analysis & Trends

  • Per Business Quant, earlier years put EBITDA Margin at -391.03% in FY2019 (+250.14 pp) and -641.17% in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 35.95%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 49.01%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.02%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 33.11%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 46.01%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -124.26%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 39.10%
10 Alx Oncology Holdings 192.12 Mn 192.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 -2,031.88%
Mar 31, 2020 -783.05%
Dec 31, 2019 -628.28%
Sep 30, 2019 -232.72%
API Access

Alx Oncology Holdings EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ALXO&period=max&api_key=YOUR_API_KEY